均瑶健康：公司采用“自主菌株突破+产学研协同深化+产能同步落地”的三位一体研发策略

Core Viewpoint - Junyao Health adopts a three-pronged R&D strategy focusing on "independent strain breakthroughs, collaborative research with academia, and synchronized capacity implementation" to enhance its probiotic product matrix and maintain a competitive edge in technology [2] Group 1: R&D Strategy - The company emphasizes core strain independent research to establish technological barriers, particularly in fermentation technology and strain selection [2] - Junyao Health collaborates with universities and research institutions to build joint laboratories, accelerating the transformation of cutting-edge research results [2] - The company is committed to evidence-based research, aiming to catch up with international leading levels and closely integrating R&D outcomes with large-scale production capacity [2] Group 2: Production and Sales - The company enhances production efficiency through intelligent manufacturing processes, improving technical parameters [2] - Junyao Health has completed multiple outsourced R&D projects and patent applications, contributing to its comprehensive industry chain from R&D to production and sales [2] - The integration of technology innovation supports the enrichment and upgrading of the probiotic product matrix, forming a complete closed-loop industry chain [2]